Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practice.
about
Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating FactorThe Effectiveness of Febrile Neutropenia Prophylaxis with Lipegfilgrastim in Routine Clinical Practice.G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use.Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review.Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review.Multicentre, Prospective Observational Study of Pegfilgrastim Primary Prophylaxis in Patients at High Risk of Febrile Neutropenia in Poland: PROFIL StudyResults of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemotherapy.Safety and tolerability of Peg-grafeel™, a pegfilgrastim, for the prophylactic treatment of chemotherapy-induced neutropenia and febrile neutropenia: A prospective, observational, postmarketing surveillance study in India.Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.Hospitalizations, outcomes, and management costs of febrile neutropenia in patients from a managed care population.Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.Adequate Neutrophil Responses and Non-Inferior Clinical Outcomes Can Be Achieved by a Two-Day Course of Low-Dose Filgrastim: A Retrospective Single Institution Experience.Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events.Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer.Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia
P2860
Q27004054-B9DD8B61-5F1B-407A-A606-4AB9C498EA2BQ33770736-1B6CF1C1-8140-41D8-B07B-8288427961BEQ34982532-A27971AA-BDC6-4915-B5F7-8943B1D41174Q35303471-D2FDA7F6-FE36-43F6-8D34-A2A1D620340BQ35894752-D90692EE-E3DC-45CA-874B-E47ACF7B507AQ36243957-E6024FD3-8B32-467C-9536-319570240897Q36885665-203CC5E8-F1D4-45F1-8664-696542035C64Q37737017-0999F4E9-939F-41F0-8828-0BF5FFF00A6AQ38225700-B6D33140-E832-43B7-BC2E-91C05489A839Q38613025-7D58261A-81B9-4ED4-8D91-7433C307E158Q41139035-C3F6CE35-6369-4055-B54D-A3D10CB94858Q42363042-69EADE9E-C874-408E-90BD-936669AA832BQ50318146-F5992837-80E2-4425-B1A2-C23E3BFFEB3CQ50584736-9C66FB6B-1EB2-448D-AFF8-A313E036A3A2Q53559623-6E52A51D-3805-4389-A3B9-F9363D4769D7Q57292845-9E66DA70-D14A-4738-B1EE-6904C645BB43
P2860
Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Effectiveness of daily versus ...... of data from current practice.
@ast
Effectiveness of daily versus ...... of data from current practice.
@en
Effectiveness of daily versus ...... of data from current practice.
@nl
type
label
Effectiveness of daily versus ...... of data from current practice.
@ast
Effectiveness of daily versus ...... of data from current practice.
@en
Effectiveness of daily versus ...... of data from current practice.
@nl
prefLabel
Effectiveness of daily versus ...... of data from current practice.
@ast
Effectiveness of daily versus ...... of data from current practice.
@en
Effectiveness of daily versus ...... of data from current practice.
@nl
P2093
P2860
P356
P1476
Effectiveness of daily versus ...... of data from current practice.
@en
P2093
A B Sánchez Heras
A Galán Brotons
C Bosch Roig
D Almenar Cubells
E Jiménez Orozco
J M Cuervo
LEARN II Study Group
M Codes M De Villena
N Díaz Fernández
P2860
P304
P356
10.1111/ECC.12043
P407
P577
2013-01-18T00:00:00Z